1. Home
  2. RBCAA vs NVCR Comparison

RBCAA vs NVCR Comparison

Compare RBCAA & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

HOLD

Current Price

$91.21

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$14.71

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBCAA
NVCR
Founded
1974
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
RBCAA
NVCR
Price
$91.21
$14.71
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $26.86
AVG Volume (30 Days)
74.8K
★ 1.4M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
★ 2.15%
N/A
EPS Growth
N/A
★ 21.79
EPS
★ 0.77
N/A
Revenue
$417,495,000.00
★ $655,353,000.00
Revenue This Year
N/A
$10.80
Revenue Next Year
$3.20
$10.83
P/E Ratio
$119.76
★ N/A
Revenue Growth
★ 8.50
8.28
52 Week Low
$63.97
$9.82
52 Week High
$102.22
$21.45

Technical Indicators

Market Signals
Indicator
RBCAA
NVCR
Relative Strength Index (RSI) 45.70 44.38
Support Level $88.88 $13.33
Resistance Level $93.78 $15.22
Average True Range (ATR) 2.00 0.65
MACD 0.07 0.11
Stochastic Oscillator 47.75 40.70

Price Performance

Historical Comparison
RBCAA
NVCR

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: